- Rituximab, sold
under the
brand name
Rituxan among others, is a
monoclonal antibody medication used to
treat certain autoimmune diseases and
types of...
-
children and
young adults with
cystic fibrosis—recombinant DNAse. 1997:
Rituxan (rituximab):
Treatment for
specific kinds of non-Hodgkin's lymphomas. In...
-
dispute over
Rituxan follow-ons". Reuters. 21
October 2010.
Archived from the
original on 2014-07-27.
Retrieved 2010-10-21. "FDA
approves Rituxan to treat...
- transplantation. In
combination with anti-CD20
monoclonal antibody rituximab (
Rituxan, Mabthera) it is
called R-DHAP or DHAP-R. [R]-DHAP
regimen consists of:...
-
combination drug
products in the
United States: rituximab/hyaluronidase (
Rituxan Hycela), trastuzumab/hyaluronidase-oysk (Herceptin Hylecta),...
- are
often of the
cytotoxic (chemotherapy) class,
including rituximab (
Rituxan)
which targets B cells, and cyclophosphamide, a drug
which reduces the...
- are infected.[citation needed] The
boxed warning for the drug
rituximab (
Rituxan)
includes a
statement that
Human polyomavirus 2
infection resulting in...
-
personalized anticancer drugs and to the
development of an antibody-based drug,
Rituxan, that is
widely used to
treat lymphoma. He is
currently married and has...
- (INN)
ritonavir (INN)
ritropirronium bromide (INN)
ritrosulfan (INN)
Rituxan Rituxan Hycela rituximab (INN)
Rivanase AQ
rivanicline (USAN, (INN)) rivaroxaban...
- Pharmaceuticals. At IDEC,
Rastetter was a co-inventor of and
developed Rituxan, the
first monoclonal antibody (MAB) to be
approved by the U.S. FDA for...
